HEALTHEQUITY, INC. — Director's Dealing 2021

Feb 3, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HEALTHEQUITY, INC. (HQY)
CIK: 0001428336
Period of Report: 2021-02-01

Reporting Person: Sacks Ian (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-02-01	Common Stock	A	2266	—	Acquired	155062	Direct
2021-02-01	Common Stock	A	984	—	Acquired	156046	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (right to buy)	$21.27	2026-02-01	Common Stock (15000)	15000	Direct
Stock Option (right to buy)	$14	2024-07-30	Common Stock (15000)	15000	Direct
Stock Option (right to buy)	$25.39	2025-03-26	Common Stock (15000)	15000	Direct
Stock Option (right to buy)	$66.06	2030-02-01	Common Stock (8024)	8024	Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest as to 1,133 shares on the date of the issuer's annual stockholder meeting held in the current fiscal year; the remainder will vest on January 31, 2022. Vested shares will be delivered to the reporting person on February 2, 2022.

F2: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vested as to 246 shares on February 1, 2021. The remaining restricted stock units vest as to 246 shares on each of May 1, August 1, and November 1, of 2021. Vested shares will be delivered to the reporting person on February 2, 2022.

F3: The option is immediately exercisable.